Goldman Sachs Upgrades Novo Nordisk (NVO) to Conviction Buy, 'Embarking on a New Compounding Cycle'
Tweet Send to a Friend
Goldman Sachs upgraded Novo Nordisk (NYSE: NVO) from Buy to Conviction Buy.Analyst Keyur Parekh ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
